Atlas Capital Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-675	Closed	-$5.43K	–	922
2022 Q3	$5.43K	Buy	+675	New	+$5.43K	﹤0.01%	768
2022 Q2	–	Sell	-675	Closed	-$10.2K	–	987
2022 Q1	$10.2K	Buy	+675	New	+$10.2K	﹤0.01%	703